Skip to main content

Biohaven Pharmaceuticals lands Khloe Kardashian as influencer of new migraine drug

Biohaven CEO Vlad Coric said the company brought on Khloe Kardashian to promote its migraine treatment to break the stigma around it.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.